2022 Q1 Form 10-Q Financial Statement

#000143774922011121 Filed on May 05, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $287.3M $223.0M
YoY Change 28.8% 2.01%
Cost Of Revenue $191.0M $142.7M
YoY Change 33.87% 0.85%
Gross Profit $96.25M $80.30M
YoY Change 19.87% 4.15%
Gross Profit Margin 33.51% 36.0%
Selling, General & Admin $29.92M $27.30M
YoY Change 9.6% -6.19%
% of Gross Profit 31.09% 34.0%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $26.14M $25.69M
YoY Change 1.78% 1.02%
% of Gross Profit 27.16% 31.99%
Operating Expenses $251.4M $199.0M
YoY Change 26.31% -0.78%
Operating Profit $35.86M $24.00M
YoY Change 49.42% 33.09%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $7.000K $10.00K
YoY Change -30.0% -89.69%
Pretax Income $35.87M $24.01M
YoY Change 49.39% 32.43%
Income Tax $8.332M $6.002M
% Of Pretax Income 23.23% 25.0%
Net Earnings $27.53M $18.01M
YoY Change 52.91% 31.26%
Net Earnings / Revenue 9.58% 8.07%
Basic Earnings Per Share $0.33 $0.22
Diluted Earnings Per Share $0.33 $0.22
COMMON SHARES
Basic Shares Outstanding 82.94M 82.76M
Diluted Shares Outstanding 83.25M 83.36M

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $66.53M $88.60M
YoY Change -24.91% 145.43%
Cash & Equivalents $66.53M $88.58M
Short-Term Investments
Other Short-Term Assets $22.38M $19.40M
YoY Change 15.34% 1.57%
Inventory
Prepaid Expenses
Receivables $126.8M $89.55M
Other Receivables $4.317M $3.400M
Total Short-Term Assets $220.0M $201.1M
YoY Change 9.44% 26.02%
LONG-TERM ASSETS
Property, Plant & Equipment $663.8M $652.6M
YoY Change 1.72% -1.62%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.545M $1.698M
YoY Change -9.01% -16.31%
Total Long-Term Assets $665.4M $654.3M
YoY Change 1.69% -1.67%
TOTAL ASSETS
Total Short-Term Assets $220.0M $201.1M
Total Long-Term Assets $665.4M $654.3M
Total Assets $885.4M $855.3M
YoY Change 3.51% 3.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $29.16M $32.06M
YoY Change -9.05% -7.93%
Accrued Expenses $37.63M $24.10M
YoY Change 56.15% 10.05%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $109.4M $97.85M
YoY Change 11.78% 7.38%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $336.0K $300.0K
YoY Change 12.0% -50.0%
Total Long-Term Liabilities $336.0K $300.0K
YoY Change 12.0% -50.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $109.4M $97.85M
Total Long-Term Liabilities $336.0K $300.0K
Total Liabilities $236.6M $220.4M
YoY Change 7.38% 2.24%
SHAREHOLDERS EQUITY
Retained Earnings $587.7M $549.1M
YoY Change 7.02% 3.79%
Common Stock $61.08M $85.85M
YoY Change -28.86% 6.94%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $648.8M $635.0M
YoY Change
Total Liabilities & Shareholders Equity $885.4M $855.3M
YoY Change 3.51% 3.69%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income $27.53M $18.01M
YoY Change 52.91% 31.26%
Depreciation, Depletion And Amortization $26.14M $25.69M
YoY Change 1.78% 1.02%
Cash From Operating Activities $39.94M $43.57M
YoY Change -8.33% 0.21%
INVESTING ACTIVITIES
Capital Expenditures -$11.92M -$31.30M
YoY Change -61.92% -32.1%
Acquisitions
YoY Change
Other Investing Activities $38.00K $37.00K
YoY Change 2.7% -5.13%
Cash From Investing Activities $409.0K -$17.42M
YoY Change -102.35% -52.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $25.00M $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$30.82M -$3.697M
YoY Change 733.57% 70.13%
NET CHANGE
Cash From Operating Activities $39.94M $43.57M
Cash From Investing Activities $409.0K -$17.42M
Cash From Financing Activities -$30.82M -$3.697M
Net Change In Cash $9.532M $22.46M
YoY Change -57.55% 380.34%
FREE CASH FLOW
Cash From Operating Activities $39.94M $43.57M
Capital Expenditures -$11.92M -$31.30M
Free Cash Flow $51.86M $74.87M
YoY Change -30.74% -16.42%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
81946496
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
192000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
192000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
81946875
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
81946875
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
83034404
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
83034404
CY2021 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0
CY2022Q1 mrtn Customer Contract Term
CustomerContractTerm
P1Y
CY2021Q1 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
66527000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
56995000 USD
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
126815000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
99003000 USD
CY2022Q1 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
4317000 USD
CY2021Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
6971000 USD
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
22375000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23980000 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
220034000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
186949000 USD
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
955760000 USD
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
956476000 USD
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
291941000 USD
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
274199000 USD
CY2021Q4 us-gaap Assets
Assets
870690000 USD
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1545000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1464000 USD
CY2022Q1 us-gaap Assets
Assets
885398000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
663819000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
682277000 USD
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
29158000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
20150000 USD
CY2022Q1 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
42592000 USD
CY2021Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
42014000 USD
CY2022Q1 mrtn Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
37632000 USD
CY2021Q4 mrtn Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
31395000 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
109382000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
93559000 USD
CY2022Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
126918000 USD
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
125163000 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
336000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
291000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
236636000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
219013000 USD
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
819000 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
830000 USD
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
60256000 USD
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
85718000 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
587687000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
565129000 USD
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
648762000 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
651677000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
885398000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
870690000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
287281000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
223046000 USD
CY2022Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
89349000 USD
CY2021Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
72998000 USD
CY2022Q1 mrtn Purchased Transportation
PurchasedTransportation
57310000 USD
CY2021Q1 mrtn Purchased Transportation
PurchasedTransportation
40765000 USD
CY2022Q1 mrtn Fuel And Fuel Tax Expense
FuelAndFuelTaxExpense
44368000 USD
CY2021Q1 mrtn Fuel And Fuel Tax Expense
FuelAndFuelTaxExpense
28937000 USD
CY2022Q1 mrtn Supplies And Maintenance Expense
SuppliesAndMaintenanceExpense
12313000 USD
CY2021Q1 mrtn Supplies And Maintenance Expense
SuppliesAndMaintenanceExpense
11015000 USD
CY2022Q1 us-gaap Depreciation
Depreciation
26143000 USD
CY2021Q1 us-gaap Depreciation
Depreciation
25687000 USD
CY2022Q1 us-gaap Taxes And Licenses
TaxesAndLicenses
2640000 USD
CY2021Q1 us-gaap Taxes And Licenses
TaxesAndLicenses
2712000 USD
CY2022Q1 us-gaap General Insurance Expense
GeneralInsuranceExpense
12704000 USD
CY2021Q1 us-gaap General Insurance Expense
GeneralInsuranceExpense
11446000 USD
CY2022Q1 mrtn Communications And Utilities Expense
CommunicationsAndUtilitiesExpense
2265000 USD
CY2021Q1 mrtn Communications And Utilities Expense
CommunicationsAndUtilitiesExpense
2083000 USD
CY2022Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
8871000 USD
CY2021Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
5389000 USD
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
251423000 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
199048000 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
35858000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
23998000 USD
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1755000 USD
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1085000 USD
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
7000 USD
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
35865000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
24008000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8332000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6002000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
27533000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
18006000 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.22
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.22
CY2022Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.06
CY2021Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.04
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
620333000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
18006000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
161000 USD
CY2021Q1 mrtn Adjustments To Additional Paid In Capital Employee Taxes Paid In Exhange For Shares Witheld
AdjustmentsToAdditionalPaidInCapitalEmployeeTaxesPaidInExhangeForSharesWitheld
547000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
336000 USD
CY2021Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
3311000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
634978000 USD
us-gaap Net Income Loss
NetIncomeLoss
67422000 USD
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
715000 USD
mrtn Adjustments To Additional Paid In Capital Employee Taxes Paid In Exhange For Shares Witheld
AdjustmentsToAdditionalPaidInCapitalEmployeeTaxesPaidInExhangeForSharesWitheld
2196000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2182000 USD
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
51424000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
651677000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
27533000 USD
CY2022Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
25000000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
768000 USD
CY2022Q1 mrtn Adjustments To Additional Paid In Capital Employee Taxes Paid In Exhange For Shares Witheld
AdjustmentsToAdditionalPaidInCapitalEmployeeTaxesPaidInExhangeForSharesWitheld
1610000 USD
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
369000 USD
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
4975000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
648762000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
27533000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
18006000 USD
CY2022Q1 us-gaap Depreciation
Depreciation
26143000 USD
CY2021Q1 us-gaap Depreciation
Depreciation
25687000 USD
CY2022Q1 mrtn Amortization Expense For Tires In Service
AmortizationExpenseForTiresInService
1562000 USD
CY2021Q1 mrtn Amortization Expense For Tires In Service
AmortizationExpenseForTiresInService
1642000 USD
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
369000 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
336000 USD
CY2022Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
26256000 USD
CY2021Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
4241000 USD
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-886000 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1445000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5572000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
677000 USD
CY2022Q1 us-gaap Increase Decrease In Insurance Liabilities
IncreaseDecreaseInInsuranceLiabilities
578000 USD
CY2021Q1 us-gaap Increase Decrease In Insurance Liabilities
IncreaseDecreaseInInsuranceLiabilities
2117000 USD
CY2022Q1 mrtn Increase Decrease In Accrued Other Current Liabilities
IncreaseDecreaseInAccruedOtherCurrentLiabilities
6338000 USD
CY2021Q1 mrtn Increase Decrease In Accrued Other Current Liabilities
IncreaseDecreaseInAccruedOtherCurrentLiabilities
-1200000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
39940000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
43570000 USD
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
38000 USD
CY2021Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
37000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
409000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17417000 USD
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
25000000 USD
CY2021Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
-0 USD
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4975000 USD
CY2021Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3311000 USD
CY2022Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
768000 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
161000 USD
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1610000 USD
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
547000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-30817000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3697000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
9532000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
22456000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
56995000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
66127000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
66527000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
88583000 USD
CY2022Q1 mrtn Increase Decrease Capital Expenditures Incurred But Not Yet Paid
IncreaseDecreaseCapitalExpendituresIncurredButNotYetPaid
4392000 USD
CY2021Q1 mrtn Increase Decrease Capital Expenditures Incurred But Not Yet Paid
IncreaseDecreaseCapitalExpendituresIncurredButNotYetPaid
5505000 USD
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
872000 USD
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1350000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
27533000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
18006000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
82938000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
82758000
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
308000
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
601000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
83246000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
83359000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.22
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.22
CY2022Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
30000000.0 USD
CY2022Q1 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2022Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
18500000 USD
CY2022Q1 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
11500000 USD
CY2022Q1 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2022Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
18500000 USD
CY2022Q1 mrtn Line Of Credit Facility Dividend Restrictions Percentage Of Net Income Limit
LineOfCreditFacilityDividendRestrictionsPercentageOfNetIncomeLimit
0.25 pure
CY2022Q1 mrtn Line Of Credit Facility Waiver To Pay Dividends Maximum
LineOfCreditFacilityWaiverToPayDividendsMaximum
80000000 USD
CY2019Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
34000000 USD
CY2019Q3 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
1800000
CY2020Q3 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
2700000
CY2022Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
1300000
CY2022Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
25000000.0 USD
CY2022Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
8400000 USD
CY2022Q1 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
1300000
CY2021Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3300000 USD
CY2022Q1 mrtn Line Of Credit Facility Dividend Restrictions Percentage Of Net Income Limit
LineOfCreditFacilityDividendRestrictionsPercentageOfNetIncomeLimit
0.25 pure
CY2022Q1 mrtn Line Of Credit Facility Waiver To Pay Dividends Maximum
LineOfCreditFacilityWaiverToPayDividendsMaximum
80000000 USD
CY2022Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
369000 USD
CY2021Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
336000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
583000 USD
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
5 pure
CY2022Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4 pure
CY2022Q1 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 USD
CY2022Q1 us-gaap Revenues
Revenues
287281000 USD
CY2021Q1 us-gaap Revenues
Revenues
223046000 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
35858000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
23998000 USD

Files In Submission

Name View Source Status
0001437749-22-011121-index-headers.html Edgar Link pending
0001437749-22-011121-index.html Edgar Link pending
0001437749-22-011121.txt Edgar Link pending
0001437749-22-011121-xbrl.zip Edgar Link pending
ex_364581.htm Edgar Link pending
ex_364582.htm Edgar Link pending
ex_364583.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mrtn-20220331.xsd Edgar Link pending
mrtn-20220331_cal.xml Edgar Link unprocessable
mrtn-20220331_def.xml Edgar Link unprocessable
mrtn-20220331_lab.xml Edgar Link unprocessable
mrtn-20220331_pre.xml Edgar Link unprocessable
mrtn20220331_10q.htm Edgar Link pending
mrtn20220331_10q_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending